Physician profile
John R Jackson
NPI 1114922911
$1,074.40
in general payments reported to CMS, 2019-2025
15 companies · $241 in 2025
The $241 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2022: $344 · 2023: $104 · 2024: $254 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $599.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $352.86 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Sage Therapeutics, LLC | $130.95 | 2024-2025 | Zurzuvae |
| Avanos Medical | $117.18 | 2019 | |
| Hologic Sales and Service, LLC | $113.63 | 2023-2025 | Fluent Fluid Management System, Sonata Sonography-Guided Transcervical Fibroid Ablation System, Thinprep 2000 Processor |
| Astellas Pharma US INC | $107.55 | 2023-2025 | Veozah |
| Channel Medsystems, INC. | $65.37 | 2023 | |
| Shield Therapeutics INC | $40.35 | 2024 | |
| Ethicon US, LLC | $38.82 | 2025 | Ethicon, Vistaseal, Stratafix |
| Pfizer INC. | $24.28 | 2022 | |
| Millicent US INC | $21.02 | 2025 | Femlyv |
| Grifols USA, LLC | $18.20 | 2025 | Thrombate III |
| Exeltis, USA INC. | $16.56 | 2025 | Slynd |
| Amag Pharmaceuticals, INC. | $13.37 | 2019 | |
| Minerva Surgical, INC | $11.76 | 2022 | |
| Mayne Pharma Commercial LLC | $2.50 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.